Illustration of person with a migraine

Your patients with headache disorders are in pain. Are they getting enough help?

Less than 5% of health systems have headache specialists, leading to long wait times, frustrated patients, and poor outcomes.

Why healthcare systems partner with Haven

Expert headache care at scale

Haven’s protocols are designed by nationally recognized subject matter experts and delivered by trained clinicians. Our team-based approach ensures care is consistent and cutting-edge.

Collaborative digital and in-person support

Haven delivers tech-enabled, high-touch telehealth services that address patient needs while supporting their connection to any necessary in-person care from their local health system.

Expanding care outside of urban areas

Our telehealth solution eliminates wait times and geographic barriers to care, making access simple for headache patients.

Driving down costs and improving outcomes for ACOs

Reduced neurology wait times, fewer trips to the ER, and increased patient satisfaction.

Haven is your turnkey headache center partner

Illustration of someone with a migraine getting a helping hand

Imagine improving your clinical outcomes, increasing revenue, and reducing your neurology wait times

Haven supports all departments

Primary care, OBGYN, Neuro, ER, and urgent care refers into haven

When patients get the care they deserve, we all benefit

Haven reduces the number of patient headache days in your system by offering:

  • Virtual visits with clinicians trained in headache medicine.
  • Personalized treatment plans for each patient.
  • Remote therapeutic monitoring to track progress and dial in treatment.
  • Access to 24/7 messaging.
Exchange of messages between haven and a patient to record headache's severity and what medications were taken

Patients get the attention they deserve through daily remote therapeutic monitoring

Using our proprietary technology and clinical protocols.

Patients stay in your system for all other services

We coordinate with your providers to keep patients in your system for in-person services like imaging, procedures, and other diagnostics.

Haven refers back into the health system for labs, imaging, interventional pain, OBGYN, and primary care

Clinical leadership & Advisors

Nada Hindiyeh, MD
Founder & Chief Medical Officer

Dr. Hindiyeh is a UCNS-certified headache specialist and former Associate Professor of Neurology at Stanford University, where she treated patients, led over 25 clinical trials as the Director of Headache Clinical Research and instructed headache fellows and neurology residents.

Susan Hutchinson, MD
Director of Headache Medicine

Dr. Hutchinson is a UCNS-certified headache specialist and the founder of the Orange County Migraine & Headache Center in Irvine, California. The driving passion in her life is to alleviate the suffering from migraine in patients’ lives and to help give them their lives back.

Andrew Blumenfeld, MD
Clinical Advisor

Dr. Blumenfeld is a UCNS-certified headache specialist, board-certified neurologist, and is one of the developers of the Botox for migraine protocol. He is also an avid researcher and holds 27 patents related to headache treatment.

Kenneth P. Martinez, MD
Clinical Advisor

Dr. Martinez is a UCNS-certified headache specialist, board-certified neurologist, and the founder of the Neurology and Pain Specialty Center in Aliso Viejo, California. He has spent more than 20 years in private practice, specializing in diagnosing and treating neurological diseases with a specific interest in headache disorders.

Evidence-based care model

Haven takes pride in the clinical rigor we bring to headache and migraine care. Our care model was developed by leading United Council for Neurologic Subspecialties (UCNS) certified headache specialists, and all our clinicians bring prior experience in headache medicine. Additionally, all our clinicians undergo an intensive onboarding process before seeing patients. We stay up-to-date on clinical evidence and guidelines from UCNS and the American Headache Society (AHS) and use purpose-built technology supported by advanced data analytics to achieve symptom control faster than traditional clinics.

Migraine symptoms

Evidence behind Haven’s model

Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update

March 11, 2024
Andrew C. Charles MD, Kathleen B. Digre MD, Peter J. Goadsby MD, PhD, Matthew S. Robbins MD, Andrew Hershey MD, PhD, The American Headache Society

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study

January 25, 2022
Richard B. Lipton MD, Robert A. Nicholson PhD, Michael L. Reed PhD, Andre B. Araujo PhD, Dena H. Jaffe PhD, Douglas E. Faries PhD, Dawn C. Buse PhD, Robert E. Shapiro MD, PhD, Sait Ashina MD, M. Janelle Cambron-Mellott PhD, John C. Rowland MS, Eric M. Pearlman MD, PhD

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

June 23, 2021
Jessica Ailani MD, Rebecca C. Burch MD, Matthew S. Robbins MD, on behalf of the Board of Directors of the American Headache Society

Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study

April 1, 2021
Dawn C. Buse PhD, Cynthia E. Armand MD, Larry Charleston IV MD, MSc, Michael L. Reed PhD, Kristina M. Fanning PhD, Aubrey Manack Adams PhD, Richard B. Lipton MD

Botulinum Toxin in the Treatment of Headache

December 17, 2020
Werner J. Becker

Migraine is first cause of disability in under 50s: will health politicians now take notice?

February 21, 2018
Timothy J. Steiner, Lars J. Stovner, Theo Vos, R. Jensen, Z. Katsarava

Your partner in headache care

Haven can help your patients manage their headaches and have more good days.

CTA image